17,400 Shares in IonQ, Inc. $IONQ Acquired by Vanguard Capital Wealth Advisors

Vanguard Capital Wealth Advisors purchased a new stake in shares of IonQ, Inc. (NYSE:IONQ) during the 3rd quarter, Holdings Channel.com reports. The fund purchased 17,400 shares of the company’s stock, valued at approximately $763,000.

A number of other hedge funds also recently made changes to their positions in the stock. BlackRock Inc. purchased a new position in shares of IonQ during the 2nd quarter valued at $1,112,945,000. Bank of America Corp DE purchased a new stake in IonQ in the 2nd quarter worth $344,757,000. Bank of New York Mellon Corp bought a new stake in IonQ during the second quarter valued at about $113,863,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of IonQ by 45.0% in the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,632,290 shares of the company’s stock valued at $86,936,000 after acquiring an additional 506,191 shares in the last quarter. Finally, Legal & General Group Plc purchased a new position in shares of IonQ in the second quarter valued at about $82,126,000. 41.42% of the stock is currently owned by institutional investors.

IonQ Stock Performance

NYSE:IONQ opened at $34.29 on Friday. IonQ, Inc. has a one year low of $25.89 and a one year high of $73.87. The firm has a 50-day simple moving average of $40.93 and a 200-day simple moving average of $44.86.

IonQ (NYSE:IONQ) last announced its earnings results on Wednesday, August 5th. The company reported ($0.33) earnings per share for the quarter, topping the consensus estimate of ($0.56) by $0.23. The firm had revenue of $80.05 million for the quarter, compared to the consensus estimate of $66.47 million. IonQ had a negative return on equity of 22.29% and a negative net margin of 553.27%. The firm’s revenue for the quarter was up 286.7% on a year-over-year basis. During the same period in the previous year, the business earned ($0.70) EPS. On average, research analysts forecast that IonQ, Inc. will post -2.11 earnings per share for the current year.

Key Stories Impacting IonQ

Here are the key news stories impacting IonQ this week:

• Positive Sentiment: IonQ priced a $2.0 billion equity offering, providing significant additional capital to accelerate commercialization, fund research and development, and pursue strategic opportunities. The financing could strengthen IonQ’s balance sheet despite near-term dilution concerns. IonQ Announces Pricing of $2.0 Billion Equity Offering
• Positive Sentiment: The planned delivery of IonQ’s 256-qubit Superion system in early 2027 offers a potential catalyst. Successful customer deployments could support demand for the company’s quantum hardware and strengthen its commercialization story. Prediction: IonQ Will Cross $100 Per Share in 2027
• Positive Sentiment: Rosenblatt reaffirmed a Buy rating, while Zacks upgraded IonQ to a Rank #2 (Buy), reflecting optimism about future earnings and the company’s long-term position in quantum computing. IonQ Upgraded to Buy
• Neutral Sentiment: IonQ agreed to acquire Elisity, a Zero Trust cybersecurity company, for up to $1.3 billion in an all-stock transaction. The deal could diversify IonQ into quantum-era security and add recurring enterprise revenue, but management has not yet provided enough guidance to assess its near-term financial contribution. IonQ to Buy Elisity for Up to $1.3B
• Negative Sentiment: The $2 billion share sale, priced at $40 per share, increases the outstanding share count and reduces existing shareholders’ ownership percentage. Investors also viewed the financing as a sign that IonQ may require substantial capital while it remains unprofitable. IonQ Announces Pricing of $2.0 Billion Equity Offering
• Negative Sentiment: Market skepticism about the Elisity deal, dilution, acquisition integration, and IonQ’s continued heavy losses has pressured the stock, despite record revenue and a growing backlog. Broader weakness across quantum-computing shares has added to the selling pressure. IonQ Slides on Elisity Deal and Dilution Risk

Insider Transactions at IonQ

In related news, insider John Raymond sold 2,407 shares of the business’s stock in a transaction on Thursday, September 10th. The shares were sold at an average price of $37.21, for a total value of $89,564.47. Following the completion of the sale, the insider owned 77,741 shares of the company’s stock, valued at approximately $2,892,742.61. The trade was a 3.00% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.55% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on IONQ shares. Morgan Stanley cut their target price on IonQ from $49.00 to $43.00 and set an “equal weight” rating for the company in a research report on Thursday. Benchmark restated a “buy” rating and issued a $60.00 price target on shares of IonQ in a research note on Thursday, August 6th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $70.00 price target on shares of IonQ in a research note on Wednesday, September 9th. Bank of America started coverage on shares of IonQ in a report on Monday, September 28th. They issued a “buy” rating and a $60.00 target price for the company. Finally, Jefferies Financial Group reiterated a “buy” rating and issued a $80.00 target price on shares of IonQ in a report on Wednesday, September 9th. Ten investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $63.33.

About IonQ

IonQ, Inc is a quantum computing company that develops and commercializes quantum computers based on trapped-ion technology. Its systems are designed to perform specialized computations that may eventually support applications in areas such as optimization, materials science, drug discovery, financial modeling and artificial intelligence.

The company offers access to its quantum processors through cloud platforms, including Amazon Web Services’ Amazon Braket, Microsoft Azure Quantum and Google Cloud.